AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 67 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | – | 17 | +6.2% | 0.00% | – |
Q2 2023 | $0 | -100.0% | 16 | -99.9% | 0.00% | – |
Q1 2023 | $37,000 | – | 20,012 | +35635.7% | 0.00% | – |
Q4 2022 | $0 | – | 56 | +27.3% | 0.00% | – |
Q3 2022 | $0 | – | 44 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 44 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 44 | +4.8% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 42 | -70.0% | 0.00% | – |
Q3 2021 | $1,000 | – | 140 | +133.3% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 60 | -78.3% | 0.00% | – |
Q1 2021 | $2,000 | +100.0% | 276 | +142.1% | 0.00% | – |
Q4 2020 | $1,000 | – | 114 | +3700.0% | 0.00% | – |
Q3 2020 | $0 | – | 3 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |